The Myeloid cells in Neurodegenerative Diseases (MyND) initiative is a collaborative effort with the goal of creating a multi-omic atlas of myeloid cells from the periphery and from autopsied brains of subjects with Parkinson’s disease (PD), Alzheimer’s disease (AD), and age-matched controls. We have generated large-scale transcriptomic profiles of CD14+ monocytes from 230 individuals with sporadic PD and age matched healthy subjects. We identified dysregulation of mitochondrial and proteasomal pathways, and single-cell analysis revealed that these pathways are enriched in the intermediate monocytes. We also generated transcriptomic profiles of primary microglia from autopsied brains of 55 PD and control subjects and observed discordant transcriptomic signatures of mitochondrial genes in PD monocytes and microglia/macrophages. ELISA NAVARRO*, EVAN UDINE*, et al. "Dysregulation of mitochondrial and proteolysosomal genes in Parkinson’s disease myeloid cells." Nature Aging, 2021. Link: <a href="https://www.biorxiv.org/content/10.1101/2020.07.20.212407v1">https://www.biorxiv.org/content/10.1101/2020.07.20.212407v1</a> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35005630/">35005630</a>

The Role of Myeloid Cells in Parkinson's Disease

Dysregulation of mitochondrial and proteolysosomal genes in Parkinson’s disease myeloid cells